Overview

N Acetyl Cysteine for Cystinosis Patients

Status:
Completed

Trial end date:
2012-05-01

Target enrollment:

Participant gender:

Summary

This study intends to verify the interference of N acetyl cysteine in the progression of chronic kidney disease in patients with Nephropathic Cystinosis.

Phase:

Phase 4

Details

Lead Sponsor:

University of Sao Paulo

Collaborator:

Fundação de Amparo à Pesquisa do Estado de São Paulo

Treatments:

Acetylcysteine
N-monoacetylcystine